Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe, and other international markets. The company's approach to precision medicine aims to deliver the right drug to the right patient at the right time, targeting specific subsets of cancer. Clovis develops diagnostic tools in collaboration with partners to direct compounds to patients most likely to benefit.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2009
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
